Literature DB >> 1736878

Blood-retinal barrier breakdown caused by diode vs argon laser endophotocoagulation.

Y Sato1, B A Berkowitz, C A Wilson, E de Juan.   

Abstract

We compared the effects of argon and diode laser endophotocoagulation on blood-retinal barrier breakdown using real-time magnetic resonance imaging following intravenous gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) injection. Endophotocoagulation was performed on eyes of pigmented rabbits with either the argon or the diode laser to produce ophthalmoscopically similar lesions. Magnetic resonance imaging studies were performed either 2 or 7 days after laser treatment, and coronal T1-weighted proton images were obtained in the first 20 minutes following Gd-DTPA injection. The mean signal intensity over a region of interest in the vitreous cavity was analyzed, and an initial rate analysis was performed on each time-course curve. Two days after treatment, argon laser-treated eyes showed significantly greater leakage of Gd-DTPA than diode laser-treated eyes. The leakage in both groups was substantially reduced by posttreatment day 7. Histopathologic examination performed 2 days following photocoagulation showed less damage of the retinal pigment epithelium and more severe occlusion of the choriocapillaris and deep choroidal vessels in diode laser-treated eyes. These changes may serve to explain the observed differences in Gd-DTPA leakage.

Entities:  

Mesh:

Year:  1992        PMID: 1736878     DOI: 10.1001/archopht.1992.01080140133040

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Comparison of tight junction permeability for albumin in iris pigment epithelium and retinal pigment epithelium in vitro.

Authors:  K A Rezai; A Lappas; L Kohen; P Wiedemann; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-01       Impact factor: 3.117

2.  A comparative study of the effects of argon and diode laser photocoagulation on retinal oxygenation.

Authors:  H Funatsu; C A Wilson; B A Berkowitz; P L Sonkin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

3.  Deferred laser photocoagulation of relaxing retinotomies under silicone oil tamponade to reduce recurrent macular detachment in severe proliferative vitreoretinopathy.

Authors:  Marc Veckeneer; Kristel Maaijwee; David G Charteris; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-18       Impact factor: 3.117

4.  Cell swelling contributes to thickening of low-dose N-methyl-D-aspartate-induced retinal edema.

Authors:  Junjie Chen; Chia-Wen Chiang; Huiying Zhang; Sheng-Kwei Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-09       Impact factor: 4.799

5.  Multicenter trial of transscleral diode laser retinopexy in retinal detachment surgery.

Authors:  J A Haller; N Blair; E de Juan; S de Bustros; M F Goldberg; T Muldoon; K Packo; K Resnick; R Rosen; M Shapiro; W Smiddy; J Walsh
Journal:  Trans Am Ophthalmol Soc       Date:  1997

6.  Comparison of pre-retinal oxygen pressure changes after selective retina therapy versus conventional photocoagulation in the rabbit eye.

Authors:  Jae Ryun Kim; Young-Gun Park; Young Jung Roh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-02       Impact factor: 3.117

Review 7.  MRI in ocular drug delivery.

Authors:  S Kevin Li; Martin J Lizak; Eun-Kee Jeong
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

8.  Novel serum proteomic signatures in a non-human primate model of retinal injury.

Authors:  Jeffrey J Dunmire; Rachida Bouhenni; Michael L Hart; Bassam T Wakim; Anthony M Chomyk; Sarah E Scott; Hiroshi Nakamura; Deepak P Edward
Journal:  Mol Vis       Date:  2011-03-23       Impact factor: 2.367

9.  Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484].

Authors:  Lalit Verma; Rajesh Sinha; Pradeep Venkatesh; H K Tewari
Journal:  BMC Ophthalmol       Date:  2004-10-29       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.